Dual specificity antibodies and methods of making and using
AssigneeAbbVie Inc.
InventorsAlbert Collinson, George Avgerinos, Richard Dixon, Tariq Ghayur, Zehra Kaymakcalan
Life of this patent
Estimating the term…
Loading patent…
AssigneeAbbVie Inc.
InventorsAlbert Collinson, George Avgerinos, Richard Dixon, Tariq Ghayur, Zehra Kaymakcalan
Estimating the term…
Antibodies having dual specificity for two different but structurally related antigens are provided. The antibodies can be, for example, entirely human antibodies, recombinant antibodies, or monoclonal antibodies. Preferred antibodies have dual specificity for IL-1α and IL-1β and neutralize IL-1α and IL-1β activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Methods of making and methods of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting two different but structurally related antigens (e.g., IL-1α and IL-1β) and for inhibiting the activity of the antigens, e.g., in a human subject suffering from a disorder in which IL-1α and/or IL-1β activity is detrimental.
A method of obtaining a dual-specificity antibody, or antigen-binding portion thereof, that specifically binds two different proteins that are members of the IL-1 cytokine family, the method comprising:
Dependencies are inferred from the claim text.